Hypoglycemia Symptoms Diabetes News
- Novo Nordisk partners with international scientific community for Victoza(R) cardiovascular outcomes trial Thursday, May 6, 2010 @ 11:42AMPRINCETON, NJ--(Marketwire - May 6, 2010) - Novo Nordisk ( NYSE : NVO ) announced today details of the company's cardiovascular outcomes trial for Victoza ® (liraglutide [rDNA origin] injection), which is set to start in the autumn of 2010.
- Poirier, Lu lead the boys, Ngo the girls, as Cupertino High swimming teams roll Thursday, May 6, 2010 @ 9:27AMWith junior Steven Poirier and freshman Osker Lu leading the boys and freshman Kelly Ngo pacing the girls, the Cupertino High School swimming teams have enjoyed a very good season so far this spring.
- Novo Nordisk partners with international scientific community for Victoza(R) cardiovascular outcomes trial Thursday, May 6, 2010 @ 7:00AMNovo Nordisk announced today details of the company's cardiovascular outcomes trial for Victoza® , which is set to start in the autumn of 2010.
- Novo Nordisk partners with international scientific community for Victoza(R) cardiovascular outcomes trial Thursday, May 6, 2010 @ 7:00AMPRINCETON, NJ--(Marketwire - 05/06/10) - Novo Nordisk (NYSE: NVO - News ) announced today details of the company's cardiovascular outcomes trial for Victoza (liraglutide [rDNA origin ] injection), which is set to start in the autumn of 2010. The trial named LEADER ( L iraglutide E ffect and A ction in D iabetes: E valuation of Cardiovascular Outcome R esults) aims to assess and confirm the ...
- SPONSORED CONTENT: It's Girl Scout Cookie Season! Wednesday, May 5, 2010 @ 12:27PMSelling Cookies Throughout LA County, Donating Cookies To Our U.S. Servicemen And Servicewomen
- Encapsulated Cell Replacement Therapy For The Treatment Of Diabetes: Phase II Clinical Trial Wednesday, April 28, 2010 @ 5:19AMThe Juvenile Diabetes Research Foundation has announced that it is partnering with Living Cell Technologies (LCT), a New Zealand-based biotechnology company focused on developing cell based therapeutics, in a Phase II clinical trial to study the safety and effectiveness of transplanting encapsulated insulin-producing cells from pigs as a treatment for type 1 diabetes with significant ...
- JDRF partners with LCT to test encapsulated cell replacement therapy for the treatment of diabetes Tuesday, April 27, 2010 @ 7:25AM( Juvenile Diabetes Research Foundation International ) The Juvenile Diabetes Research Foundation announced today that it is partnering with Living Cell Technologies, a New Zealand-based biotechnology company focused on developing cell based therapeutics, in a Phase II clinical trial to study the safety and effectiveness of transplanting encapsulated insulin-producing cells from pigs as a ...
- Hospital news Saturday, April 24, 2010 @ 10:39PM561 W. Central Ave. For more information on the following programs or to register, contact the Grady Life Center at (800) 837-7555, (614) 4-HEALTH, or visit www.ohiohealth.com. Classes are held at the hospital unless otherwise noted.
- Artificial pancreas for type 1 diabetes patients Wednesday, February 10, 2010 @ 1:53AMResearchers at the University of Cambridge have developed an artificial pancreas device that can improve overnight blood sugar control, which brings new hope for type 1 diabetes patients, media reported Monday. One problem facing type 1 diabetics is hypoglycemia; a condition in which blood sugar drops to dangerously low levels after the use of insulin. Type 1 diabetics must use insulin; however ...
- Too-Strict Blood Sugar Control May Lead to Car Crashes Tuesday, December 8, 2009 @ 1:34PMDriver's license approvals for diabetics should be re-evaluated, expert says
- Too-Strict Blood Sugar Control May Lead to Car Crashes Tuesday, December 8, 2009 @ 1:03PMTUESDAY, Dec. 8 (HealthDay News) -- Diabetics who keep their blood sugar tightly controlled run the risk of having traffic accidents due to low blood sugar, Canadian researchers report.